Dinar Daily
Welcome to Dinar Daily Discussions.

Logging in with your USERNAME allows you to participate in discussions, see what has recently been posted, and other options. Guests can post but they do have limited abilities.

We are NOT a guru forum. We are a dinarian forum. The opinions expressed on the forum do not reflect the of opinion of Dinar Daily specifically, but rather reflect the views of the individual posters only.

Disclamer:

We are in compliance with, "Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favor of fair use."


Get Daily Updates of the NEWS & GURUS in your EMAIL
CHECK YOUR EMAIL for VERIFICATION

Enter your email address:

Julphar appoints a new CEO to drive operational transformation and support growth DinarDailyUpdates?bg=330099&fg=FFFFFF&anim=1

Julphar appoints a new CEO to drive operational transformation and support growth

Go down

Julphar appoints a new CEO to drive operational transformation and support growth Empty Julphar appoints a new CEO to drive operational transformation and support growth

Post by claud39 on Sun Apr 05, 2020 9:03 am

Julphar appoints a new CEO to drive operational transformation and support growth




04/04/2020



Julphar appoints a new CEO to drive operational transformation and support growth 19898







The Economy News - Baghdad

Gulf Pharmaceutical Industries "Julphar" announced the appointment of Issam Farouk as its CEO, explaining that this decision comes in light of the company's pioneering transformation program in the Middle East and other regions.

A statement of the company, which was received by "Al-Eqtisad News", stated that Farouk will lead "the growth and development of (Julphar) Company through its continuous commitment to raise the level of its facilities, operations, practices and infrastructure in a manner that ensures the continuity of the company with durability during the year 2020 and the coming years"

The statement added that "it will contribute to consolidating (Julphar) position in the market as a pioneer in the field of medicines in the region, by working to complete its mission to provide high-quality solutions and enhance the health of people at the regional and global levels."

"I am proud to join an organization that is at the heart of the UAE and continues to contribute to economic growth in Ras al-Khaimah and abroad. I look forward to working with a highly skilled team in the coming months, as we aim to continue ensuring the production of high-quality drugs," the statement quoted Farouk as saying. , As well as creating value-added products and healthcare solutions that change the lives of the people who need them most, I am fully committed to restoring Julphar's position as a regionally leading pharmaceutical industry company within three years.

In turn, Sheikh Saqr bin Humaid Al Qasimi, Chairman of Julphar, said in the statement that “Dr. Essam’s proven track record in the pharmaceutical industry in addition to his extensive experience in the pharmaceutical industry in both established and emerging markets is the best proof of his leadership in the pioneering transformation processes. In business, in addition to his strategic planning and ensuring the stages of implementing strategies, his ability to manage a diverse organization and push it to success and enhance its business in difficult environments would ensure the huge impact of Julphar in the 50 markets where we operate all over the world. 
"
It is noteworthy that Essam Farouk previously held the position of CEO of the "Canadian" pharmaceutical products company, where he took over the management of the company since its establishment in 2006. Through his exceptional leadership, the company witnessed exceptional growth as it became the second largest pharmaceutical company in Algeria and North Africa.

After that, he held the position of CEO of the group "MS Pharma" for seven years, as the transformation brought about by the company made it one of the five largest leading pharmaceutical companies in the Middle East and North Africa.

He also held senior positions in several companies, including the GlaxoSmithKline, Sanofi Aventis, the T3A Pharma Group and Julphar Germany, thereby accumulating a wealth of valuable experiences across public and multinational business environments.

He holds a Bachelor's degree in Pharmacy from the University of "Zagazig", in addition to obtaining a master's degree in Total Quality Management and Operations Management from the American University in Cairo and the American Quality Association.





claud39
claud39
VIP Member
VIP Member

Posts : 14287
Join date : 2018-11-04

Back to top Go down

Back to top


 
Permissions in this forum:
You cannot reply to topics in this forum